Ribonucleotide reductase as a chemotherapeutic target
- 31 December 1988
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 27, 437-455
- https://doi.org/10.1016/0065-2571(88)90030-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY)Pharmacology & Therapeutics, 1985
- Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivativesPharmacology & Therapeutics, 1985
- Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivativesBiochemical Pharmacology, 1985
- THIOREDOXINAnnual Review of Biochemistry, 1985
- Inhibition of ribonucleotide reductase by α-(N)-heterocyclic carboxaldehyde thiosemicarbazonesPharmacology & Therapeutics, 1984
- Nature and properties of mammalian ribonucleoside diphosphate reductasePharmacology & Therapeutics, 1984
- Role of ribonucleotide reductase in cell divisionPharmacology & Therapeutics, 1983
- Studies of N-hydroxy-N'-aminoguanidine derivatives by nitrogen-15 nuclear magnetic resonance spectroscopy and as ribonucleotide reductase inhibitorsJournal of Medicinal Chemistry, 1983
- Reduction of RibonucleotidesAnnual Review of Biochemistry, 1979
- Components and control of ribonucleotide reductase system of the ratAdvances in Enzyme Regulation, 1977